Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity. It offers Revita, an outpatient endoscopic procedure designed to modify duodenal dysfunction via hydrothermal ablation to restore metabolic health; and Rejuva, a novel adeno-associated virus-delivered pancreatic gene therapy platform that alters metabolic hormone function in the pancreatic islet cells of patients.